Details

Autor(en) / Beteiligte

• Tan, Vivian S
• Tjong, Michael C
• Chan, Wing C
• Yan, Michael
• Delibasic, Victoria
• Darling, Gail
• Davis, Laura E
• Doherty, Mark
• Hallet, Julie
• Kidane, Biniam
• Mahar, Alyson
• Mittmann, Nicole
• Parmar, Ambika
• Tan, Hendrick
• Wright, Frances C
• Coburn, Natalie G
• Louie, Alexander V

Titel

Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis

Ist Teil von

• Current oncology (Toronto), 2023-03, Vol.30 (3), p.3461-3472

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2023

Link zum Volltext

Quelle

Elektronische Zeitschriftenbibliothek (Open access)

Beschreibungen/Notizen

• Pain is a common symptom in stage IV non-small cell lung cancer (NSCLC). The objective of the study was to examine the use of interventions and factors associated with interventions for pain. A population-based cohort study in Ontario, Canada was conducted with patients diagnosed with stage IV NSCLC from January 2007 to September 2018. An Edmonton Symptom Assessment System (ESAS) score of ≥4 defined moderate-to-severe pain following diagnosis. The study cohort included 13,159 patients, of which 68.5% reported at least one moderate-to-severe pain score. Most patients were assessed by a palliative care team (85.4%), and the majority received radiation therapy (73.2%). The use of nerve block was rare (0.8%). For patients ≥65 years of age who had drug coverage, 59.6% received an opiate prescription. Patients with moderate-to-severe pain were more likely to receive palliative assessment or radiation therapy compared to patients with none or mild pain. Patients aged ≥70 years and with a greater comorbidity burden were associated with less likelihood to receive radiation therapy. Patients from rural/non-major urban residence and with a greater comorbidity burden were also less likely to receive palliative care assessment. Factors associated with interventions for pain are described to inform future symptom management in this population.